Table 1A

Continued

 Lund Nilsen et al., Norway,642 prostate cancer patients<23.01.00<66.51.00
  1999a (32) (Born after 1964)23.1–24.70.8 (0.6–1.1)66.5–68.11.1 (0.9–1.4)
24.8–26.21.0 (0.8–1.3)68.2–69.31.1 (0.8–1.4)
26.3–28.20.9 (0.7–1.2)69.4–70.91.2 (0.9–1.5)
>28.21.0 (0.8–1.3)>70.91.2 (0.9–1.6)
481 localized cases<66.51.0
66.5–68.10.9 (0.7–1.3)
68.2–69.30.9 (0.7–1.3)
69.4–70.91.0 (0.7–1.5)
>70.91.0 (0.7–1.4)
161 metastatic cases<66.51.0
66.5–68.11.5 (1.0–2.2)
68.2–69.30.9 (0.8–1.5)
69.4–70.91.3 (0.8–2.1)
>70.91.5 (0.9–2.6)
Cohort studies: mortality
 Snowdon et al., Seventh Day Adventist, United States of84 prostate cancer deaths (Born before 1920), agePercentage of desirable weight
 America 1984 (39) 60+70–891.6 (0.7–3.4)
90–1091.0
110–1291.2 (0.8–2.0)
130–2492.4 (1.3–4.5)
 Garfinkel CPS-I. United(Born before 1929)Weight only (pounds)0.9
  States of America 1986110–1191.37
  (40)120–1291.33
130–1391.29
140+
 Andersson, et al., Swedish,708 prostate cancer deaths<22.21.00<67.71.00
  1997 (37) (1971–1975), age 20+22.2–24.11.36 (1.03–1.79)67.7–69.30.99 (0.82–1.18)
24.2–26.21.33 (1.02–1.74)69.4–70.91.08 (0.88–1.34)
>26.21.40 (1.09–1.81)>70.91.28 (1.02–1.60)
  • a Height converted to inches.